In line, different studies in which either the binding of MID1 to mutant HTT mRNA (Matthes et al., 2018b) or the assembly of the MID1 protein complex had been pharmacologically blocked (Arnoux et al., 2018), showed reduced HTT translation and reduced behavioral aberrations in HD models. The gene discussed is HTT; the disease is Huntington disease.